Preclinical Data May Support Single Study For Pediatric Cancer Drugs – Cmte.
Pediatric efficacy of oncology drugs may be shown through one clinical trial with supportive preclinical data, the Pediatric Subcommittee of FDA's Oncologic Drugs Advisory Committee suggested March 17
You may also be interested in...
FDA should confirm whether using juvenile animals to evaluate pediatric drug safety is more predictive of the clinical experience than current practice, AstraZeneca says in comments on a proposed agency guidance
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials